Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue, net $ 3,978,000 $ 5,041,000
Cost of sales (1,744,000) (2,448,000)
Gross profit 2,234,000 2,593,000
Expenses    
General and administrative 5,367,000 6,998,000
Sales and marketing 549,000 732,000
Research and development 212,000 412,000
Restructuring expenses 0 3,843,000
Depreciation and amortization 236,000 327,000
Total expenses 6,364,000 12,312,000
Loss from operations (4,130,000) (9,719,000)
Other Expense (Income), net    
Interest (income)/expense and amortization of debt issuance cost (17,000) 2,109,000
Loss (gain) on remeasurement of warrant liability 44,000 (490,000)
Loss on debt extinguishment, net 0 2,263,000
Foreign exchange (gain) loss (45,000) 211,000
Other expense (income), net 39,000 (51,000)
Total other expenses, net 21,000 4,042,000
Loss before income taxes and equity investment loss (4,151,000) (13,761,000)
Equity investment share of loss 0 64,000
Loss from continuing operations (4,151,000) (13,825,000)
Income (loss) from discontinued operations 70,000 (2,315,000)
Net loss $ (4,081,000) $ (16,140,000)
Net loss per share:    
Basic from continuing operations (USD per share) $ (0.09) $ (0.50)
Diluted from continuing operations (USD per share) (0.09) (0.50)
Basic from discontinued operations (USD per share) 0 (0.08)
Diluted from discontinued operations (USD per share) 0 (0.08)
Net loss per share - basic (USD per share) (0.09) (0.58)
Net loss per share - diluted (USD per share) $ (0.09) $ (0.58)
Weighted-average common shares outstanding - basic (in shares) 43,903,285 27,960,584
Weighted-average common shares outstanding - diluted (in shares) 43,903,285 27,960,584